Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-22 of 22
Keywords: non-alcoholic fatty liver disease (NAFLD)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2024) 138 (12): 757–760.
Published: 19 June 2024
... receptor (LXR) non-alcoholic fatty liver disease (NAFLD) The authors of the original article “Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C” (DOI: 10.1042/CS20100387 ) would like to correct...
Articles
Ilaria Barchetta, Francesco Angelico, Maria Del Ben, Michele Di Martino, Flavia Agata Cimini, Laura Bertoccini, Licia Polimeni, Carlo Catalano, Antonio Fraioli, Riccardo Del Vescovo, Sergio Morini, Marco Giorgio Baroni, Maria Gisella Cavallo
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (19): 1753–1762.
Published: 31 August 2016
... 55.4% of T2D patients had non-alcoholic fatty liver disease (NAFLD); they were significantly younger and more insulin-resistant than non-NAFLD subjects. ADIPO-IR was the main determinant of HFF independently of age, sex, HOMA-IR, VAT, SAT and predicted severe NAFLD with the area under the receiver...
Articles
Daniel J. Cuthbertson, Fariba Shojaee-Moradie, Victoria S. Sprung, Helen Jones, Christopher J.A. Pugh, Paul Richardson, Graham J. Kemp, Mark Barrett, Nicola C. Jackson, E. Louise Thomas, Jimmy D. Bell, A. Margot Umpleby
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (2): 93–104.
Published: 09 December 2015
...Daniel J. Cuthbertson; Fariba Shojaee-Moradie; Victoria S. Sprung; Helen Jones; Christopher J.A. Pugh; Paul Richardson; Graham J. Kemp; Mark Barrett; Nicola C. Jackson; E. Louise Thomas; Jimmy D. Bell; A. Margot Umpleby Non-alcoholic fatty liver disease (NAFLD) is associated with multi-organ...
Articles
Hédia Boujedidi, Olivier Robert, Alexandre Bignon, Anne-Marie Cassard-Doulcier, Marie-Laure Renoud, Hélène Gary-Gouy, Patrice Hemon, Hugo Tharinger, Sophie Prévot, Françoise Bachelerie, Sylvie Naveau, Dominique Emilie, Karl Balabanian, Gabriel Perlemuter
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (4): 257–267.
Published: 17 October 2014
... in the abnormal chemotaxis of CXC chemokine ligand 12 (CXCL12) in several mouse models of NASH and the relevance in the context of human non-alcoholic fatty liver disease (NAFLD). We assessed chemotactic responsiveness of CD4 + T-cells to CXCL12, the effect of AMD3100, a CXC chemokine receptor 4 (CXCR4...
Includes: Supplementary data
Articles
Gonenc Kocabay, Can Yucel Karabay, Yasar Colak, Vecih Oduncu, Arzu Kalayci, Taylan Akgun, Ahmet Guler, Cevat Kirma
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (4): 297–304.
Published: 22 October 2013
... © The Authors Journal compilation © 2014 Biochemical Society 2014 2D-speckle tracking echocardiography left atrial deformation left ventricular diastolic dysfunction non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis • Echocardiography is a simple and widely...
Articles
Alisan Kahraman, Jan-Peter Sowa, Martin Schlattjan, Svenja Sydor, Martin Pronadl, Alexander Wree, Anja Beilfuss, Alpaslan Kilicarslan, Akif Altinbaş, Lars Peter Bechmann, Wing-Kin Syn, Guido Gerken, Ali Canbay
Journal:
Clinical Science
Clin Sci (Lond) (2013) 125 (8): 391–400.
Published: 14 June 2013
... adiponectin bariatric surgery fetuin-A non-alcoholic fatty liver disease (NAFLD) • BAS improves metabolic function and overall health, although underlying mechanisms remain unclear. • In the cohort described in the present paper, high cell death was associated with increased hepatic fetuin...
Includes: Supplementary data
Articles
Djordje G. Jakovljevic, Kate Hallsworth, Pawel Zalewski, Christian Thoma, Jacek J. Klawe, Christopher P. Day, Julia Newton, Michael I. Trenell
Journal:
Clinical Science
Clin Sci (Lond) (2013) 125 (3): 143–149.
Published: 12 April 2013
[email protected]. ). 17 12 2012 22 2 2013 5 3 2013 5 3 2013 © The Authors Journal compilation © 2013 Biochemical Society 2013 blood pressure variability exercise heart rate variability non-alcoholic fatty liver disease (NAFLD) HR interval variability was calculated...
Articles
Chiara Imarisio, Elisa Alchera, Salvatore Sutti, Guido Valente, Francesca Boccafoschi, Emanuele Albano, Rita Carini
Journal:
Clinical Science
Clin Sci (Lond) (2012) 123 (5): 323–332.
Published: 16 May 2012
...-alcoholic fatty liver disease (NAFLD) survival pathway NAFLD (non-alcoholic fatty liver disease) is characterized by lipid accumulation within the hepatocytes and is considered the hepatic manifestation of the so-called ‘metabolic syndrome’ being associated with visceral obesity, insulin resistance...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2012) 123 (4): 259–270.
Published: 30 April 2012
.... Food and Drug Administration has recommended measures to determine the safety of GZ and to further restrict its use [ 25 ]. © The Authors Journal compilation © 2012 Biochemical Society 2012 insulin resistance non-alcoholic fatty liver disease (NAFLD) obesity rosuvastatin sterol-regulatory...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (7): 285–286.
Published: 13 December 2010
... fatty liver disease (NAFLD) single nucleotide polymorphism viral hepatitis HCV (hepatitis C virus) infection is often asymptomatic but, once established, chronic infection can progress to scarring of the liver (i.e. fibrosis) and, generally after many years, to advanced scarring (i.e. cirrhosis...
Articles
Rika Iwata, Katharina Baur, Bruno Stieger, Joachim C. Mertens, Ann K. Daly, Pascal Frei, Julia Braun, Athanasios Vergopoulos, Felix Stickel, Karim Sabrane, Ina V. Martin, Johannes Schmitt, Oliver Goetze, Chris P. Day, Beat Müllhaupt, Andreas Geier, the Swiss Hepatitis C Cohort Study Group
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (7): 287–296.
Published: 13 December 2010
... [email protected] ). 4 5 2010 23 9 2010 30 9 2010 30 9 2010 © The Authors Journal compilation © 2011 Biochemical Society 2011 bile acid transport bile salt export pump (BSEP) cirrhosis farnesoid X receptor (FXR) non-alcoholic fatty liver disease (NAFLD) single...
Articles
Elena Lima-Cabello, María Victoria García-Mediavilla, María E. Miquilena-Colina, Javier Vargas-Castrillón, Tamara Lozano-Rodríguez, Miguel Fernández-Bermejo, José Luis Olcoz, Javier González-Gallego, Carmelo García-Monzón, Sonia Sánchez-Campos
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (6): 239–250.
Published: 03 December 2010
... 8 10 2010 © The Authors Journal compilation © 2011 Biochemical Society 2011 chronic hepatitis C virus (HCV) infection inflammation lipogenesis liver X receptor (LXR) non-alcoholic fatty liver disease (NAFLD) NAFLD (non-alcoholic fatty liver disease) is one of the most...
Articles
Maria Luisa Balmer, Jeannine Joneli, Alain Schoepfer, Felix Stickel, Wolfgang Thormann, Jean-François Dufour
Journal:
Clinical Science
Clin Sci (Lond) (2010) 119 (10): 431–436.
Published: 05 August 2010
.../by-nc/2.5/ ) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. adiponectin chronic liver disease cirrhosis hepatic fibrosis metabolic syndrome non-alcoholic fatty liver disease (NAFLD) Adiponectin...
Includes: Supplementary data
Articles
Vanessa Souza-Mello, Bianca M. Gregório, Fernando S. Cardoso-de-Lemos, Laís de Carvalho, Márcia B. Aguila, Carlos A. Mandarim-de-Lacerda
Journal:
Clinical Science
Clin Sci (Lond) (2010) 119 (6): 239–250.
Published: 08 June 2010
... compilation © 2010 Biochemical Society 2010 angiotensin II type 1 receptor blocker (ARB) dipeptidyl peptidase IV inhibitor (DPP-IV inhibitor) insulin resistance metformin metabolic syndrome non-alcoholic fatty liver disease (NAFLD) Abnormal visceral fat storage is directly related...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2010) 118 (12): 691–705.
Published: 30 March 2010
... Biochemical Society 2010 fibrosis hepatocellular carcinoma ischaemia/reperfusion injury non-alcoholic fatty liver disease (NAFLD) nuclear factor κB (NF-κB) regeneration NF-κB (nuclear factor κB) was first described in 1986 as a nuclear transcription factor required for immunoglobulin kappa...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (7): 539–564.
Published: 02 March 2009
... (email [email protected] ). 27 6 2008 27 8 2008 7 10 2008 © The Authors Journal compilation © 2009 Biochemical Society 2009 diabetes inflammation mitochondrion non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) obesity NAFLD (non...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (5): 401–402.
Published: 02 February 2009
... a great potential to initiate translational studies on NAFLD and NASH. 2 12 2008 4 12 2008 4 12 2008 © The Authors Journal compilation © 2009 Biochemical Society 2009 diabetes magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD) NMR steatohepatitis...
Articles
Jeremy F. L. Cobbold, Quentin M. Anstee, Robert D. Goldin, Horace R. T. Williams, Helen C. Matthews, Bernard V. North, Nathan Absalom, Howard C. Thomas, Mark R. Thursz, Roger D. Cox, Simon D. Taylor-Robinson, I. Jane Cox
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (5): 403–413.
Published: 02 February 2009
... 2009 Biochemical Society 2009 diabetes magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD) NMR steatohepatitis NAFLD (non-alcoholic fatty liver disease) represents a spectrum of liver disease encompassing steatosis (fatty change), NASH (non-alcoholic...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (5): 141–150.
Published: 01 August 2008
... liver non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) obesity Figure 1 The natural history of NAFLD The majority of individuals with early NAFLD (simple hepatic steatosis) do not progress to NASH. However, those individuals that do are at far higher risk...
Articles
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (1): 1–12.
Published: 02 June 2008
... Society 2008 atherosclerosis cardiovascular disease energy homoeostasis fatty acid metabolic syndrome non-alcoholic fatty liver disease (NAFLD) NAFLD (non-alcoholic fatty liver disease) encompasses the spectrum of fatty liver diseases seen in individuals with the MS (metabolic syndrome...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (8): 543–545.
Published: 13 March 2008
... compilation © 2008 Biochemical Society 2008 fasting fatty liver 3-hydroxybutyrate lipid 1 H-magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD) By extension, the findings from the present study by Moller et al. [ 5 ] may explain why rapid weight loss, in particular...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (8): 547–552.
Published: 13 March 2008
... to the declaration of Helsinki (2000) of the World Medical Association. fasting fatty liver 3-hydroxybutyrate lipid 1 H-magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD) NAFLD (non-alcoholic fatty liver disease) is prevalent in obese subjects and is considered, by many...